BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6610078)

  • 21. Determination of aromatization of 19-oxygenated 16 alpha-hydroxyandrostenedione with human placental microsomes by high-performance liquid chromatography coupled with coulometric detection.
    Numazawa M; Konno T; Furihata R; Ishikawa S
    J Steroid Biochem; 1990 Jul; 36(4):369-75. PubMed ID: 2391967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of [3H]methyltrienolone to androgen receptor in rat liver.
    Kyakumoto S; Sato N; Nemoto T; Ohara-Nemoto Y; Ota M
    Biochim Biophys Acta; 1984 Aug; 800(3):214-9. PubMed ID: 6331850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial external genital ambiguity due to a transformation defect of androgen-receptor complexes that is expressed with 5 alpha-dihydrotestosterone and the synthetic androgen methyltrienolone.
    Kaufman M; Pinsky L; Bowin A; Au MW
    Am J Med Genet; 1984 Jul; 18(3):493-507. PubMed ID: 6332533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P-450 and the aromatization of 16alpha-hydroxytestosterone and androstenedione by human placental microsomes.
    Canick JA; Ryan KJ
    Mol Cell Endocrinol; 1976 Dec; 6(2):105-15. PubMed ID: 1001810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The quantitative distribution of cytosolic androgen receptors in microdissected areas of the male rat brain: effects of estrogen treatment.
    Handa RJ; Roselli CE; Horton L; Resko JA
    Endocrinology; 1987 Jul; 121(1):233-40. PubMed ID: 3496208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid control of sexual behavior and brain aromatase in the dove: effects of nonaromatizable androgens, methyltrienolone (R1881), and 5 alpha-dihydrotestosterone.
    Hutchison JB; Joris S; Hutchison RE; Steimer T
    Horm Behav; 1989 Dec; 23(4):542-55. PubMed ID: 2606467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aromatase activity in a rat Leydig cell tumor.
    Orczyk GP; Mordes JP; Longcope C
    Endocrinology; 1987 Apr; 120(4):1482-9. PubMed ID: 3030702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome.
    Cole PA; Robinson CH
    Biochem J; 1990 Jun; 268(3):553-61. PubMed ID: 2363692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in testosterone metabolism associated with the evolution of placental and gonadal isozymes of porcine aromatase cytochrome P450.
    Corbin CJ; Trant JM; Walters KW; Conley AJ
    Endocrinology; 1999 Nov; 140(11):5202-10. PubMed ID: 10537150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different in vitro metabolism of 7 alpha-methyl-19-nortestosterone by human and equine aromatases.
    Moslemi S; Dintinger T; Dehennin L; Silberzahn P; Gaillard JL
    Eur J Biochem; 1993 Jun; 214(2):569-76. PubMed ID: 8513806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aromatization of 15 alpha and 16 alpha hydroxylated androgens in the human placental using [1,2-3H]-substrates.
    Cantineau R; Kremers P; De Graeve J; Gielen JE; Lambotte R
    J Steroid Biochem; 1982 Feb; 16(2):157-63. PubMed ID: 7078154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an androgen receptor in the human placenta.
    McCormick PD; Razel AJ; Spelsberg TC; Coulam CB
    Am J Obstet Gynecol; 1981 May; 140(1):8-13. PubMed ID: 6971572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic properties of human placental aromatase. Application of an assay measuring 3H2O release from 1beta,2beta-3H-androgens.
    Reed KC; Ohno S
    J Biol Chem; 1976 Mar; 251(6):1625-31. PubMed ID: 3502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen dependence of oestrogen production by human placental microsomes and cultured choriocarcinoma cells.
    Aw TY; Jones DP; O'Shannessy DJ; Priest JH; Priest RE
    J Steroid Biochem; 1985 Jun; 22(6):753-8. PubMed ID: 4021479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of action of the aromatase inhibitor, 4-hydroxyandrostenedione.
    Abul-Hajj YJ
    Steroids; 1983 Jun; 41(6):783-90. PubMed ID: 6665821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and binding of androgens in the spinal cord of the rat.
    MacLusky NJ; Clark CR; Shanabrough M; Naftolin F
    Brain Res; 1987 Sep; 422(1):83-91. PubMed ID: 3499956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for separate sites for aromatisation of androstenedione and 16 alpha-hydroxyandrostenedione in human placental microsomes.
    Purohit A; Oakey RE
    J Steroid Biochem; 1989 Sep; 33(3):439-48. PubMed ID: 2779235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aromatization of androstenedione and 16alpha-hydroxyandrostenedione in human placental microsomes. Kinetic analysis of inhibition by the 19-oxygenated and 3-deoxy analogs.
    Numazawa M; Watari Y; Komatsu S; Yamashita K; Nagaoka M
    Steroids; 2008 Nov; 73(12):1262-9. PubMed ID: 18611405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
    Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.